View All HCPCS Sections

• M1299

  Influenza immunization administered or previously received

• M1300

  Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)

• M1301

  Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)

• M1302

  Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed

• M1303

  Hospice services provided to patient any time during the measurement period

• M1304

  Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

• M1305

  Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period

• M1306

  Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period

• M1307

  Documentation stating the patient has received or is currently receiving palliative or hospice care

• M1308

  Influenza immunization was not administered, reason not given

• M1309

  Palliative care services provided to patient any time during the measurement period

• M1310

  Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user

• M1311

  Anaphylaxis due to the vaccine on or before the date of the encounter

• M1312

  Patient not screened for tobacco use

• M1313

  Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period

• M1314

  Bmi not documented and no reason is given

• M1315

  Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified

• M1316

  Current tobacco non-user

• M1317

  Patients who are counseled on connection with a csp and explicitly opt out

• M1318

  Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp

• M1319

  Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening

• M1320

  Patients who screened positive for at least 1 of the 5 hrsns

• M1321

  Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg

• M1322

  Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye

• M1323

  Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented

• M1324

  Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)

• M1325

  Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)

• M1326

  Patients with a diagnosis of hypotony

• M1327

  Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks

• M1328

  Patients with a diagnosis of acute vitreous hemorrhage

• M1329

  Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter

• M1330

  Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)

• M1331

  Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam

• M1332

  Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks

• M1333

  Acute vitreous hemorrhage

• M1334

  Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter

• M1335

  Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)

• M1336

  Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks

• M1337

  Acute pvd

• M1338

  Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period

• M1339

  Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period

• M1340

  Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period

• M1341

  Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period

• M1342

  Patients who died during the performance period

• M1343

  Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses

• M1344

  Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score

• M1345

  Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score

• M1346

  Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period

• M1347

  Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing)

• M1348

  Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent)

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.